RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 801–900 of 1,027
Zeng, F., Liu, Y., Huang, W., Qing, H., Kadowaki, T., Kashiwazaki, H., Ni, J., & Wu, Z. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15096 · Cited by 70
“RAGE up-regulation has been found in the brains of both AD patients and AD mouse models, suggesting that RAGE is involved in the pathological Aβ accumulation in the AD brain (Miller et al., 2008; Du Yan et al., 1996).”
BackgroundLi, Y., Zhou, S., Li, J., Sun, Y., Hamlati, H., Liu, R., & Zhang, T. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.003 · Cited by 71
Microglial interaction with β‐amyloid: Implications for the pathogenesis of Alzheimer's disease
Bamberger, M. E., & Landreth, G. E. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1121 · Cited by 70
“Stern and colleagues have shown that RAGE exacerbates oxidative stress in neurons, in part by mediating the association of amyloid with the neuron.”
InfluentialMAPK, β-amyloid and synaptic dysfunction: the role of RAGE
Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 70
Self-citationKoriyama, Y., Furukawa, A., Muramatsu, M., Takino, J.-I., & Takeuchi, M. (2015) · Scientific Reports · doi:10.1038/srep13313 · Cited by 77
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 75
MacLean, M., Derk, J., Ruiz, H. H., Juranek, J. K., Ramasamy, R., & Schmidt, A. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.012 · Cited by 69
Self-citationDecandia, D., Gelfo, F., Landolfo, E., Balsamo, F., Petrosini, L., & Cutuli, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065921 · Cited by 70
Advanced glycation end products (AGEs) activate mast cells
Sick, É., Brehin, S., André, P., Coupin, G., Landry, Y., Takeda, K., & Gies, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00905.x · Cited by 73
“…161 442–455 © 2010 The Authors British Journal of Pharmacology © 2010 The British Pharmacological Society and diabetes (Brownlee, 1992), amyloidosis (Yan et al., 1996), tumours (Taguchi et al., 2000), diabetic vascular dysfunction (Park et al., 1998) and cardiac diastolic dysfunction (Li et…”
BackgroundAntibodies and protein misfolding: From structural research tools to therapeutic strategies
Genst, E. D., Messer, A. C., & Dobson, C. M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.08.016 · Cited by 77
Investigational drugs in Alzheimer's disease: current progress
Berk, C., Paul, G., & Sabbagh, M. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.905542 · Cited by 69
Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.021 · Cited by 69
Su, G. C., Arendash, G. W., Kalaria, R. N., Bjugstad, K. B., & MULLAN, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01143-3 · Cited by 71
Praticò, D., Iuliano, L., Amerio, G., Tang, L. X., Rokach, J., Sabatino, G., & Violi, F. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<795::aid-ana15>3.0.co;2-# · Cited by 69
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 74
Interfacially Polymerized Particles with Heterostructured Nanopores for Glycopeptide Separation
Song, Y., Li, X., Fan, J., Kang, H., Zhang, X., Chen, C., Liang, X., & Wang, S. (2018) · Advanced Materials · doi:10.1002/adma.201803299 · Cited by 71
Lei, W., Cheng, Y., Liu, X., Gao, J., Zhu, Z., Ding, W., Xu, X., Li, Y., Ling, Z., Jiang, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582119 · Cited by 68
“For example, Yan et al. demonstrated that A b activates microglia by binding to the receptor for advanced glycation end products (RAGE), leading to the release of cytokines such as TNF-a and IL-6 (20).”
InfluentialSelf-citationDamage-associated molecular patterns and their pathological relevance in diabetes mellitus
Shin, J. J., Lee, E. K., Park, T. J., & Kim, W. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.06.004 · Cited by 74
Franciosi, S., Ryu, J. K., Choi, H. B., Radov, L., Kim, S. U., & McLarnon, J. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2490-06.2006 · Cited by 68
“These include RAGE (receptor of advanced glycation end products) (Yan et al., 1996), scavenger receptor class-A (El Khoury et al., 1996), serpin enzyme complex (Boland et al., 1996), formyl peptide receptor (Lorton et al., 2000), and a cell surface complex composed of integrin and…”
BackgroundKavanaugh, B., Beesley, J., Itoh, T., Itoh, A., Grinspan, J. B., & Pleasure, D. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6<725::aid-jnr4>3.0.co;2-v · Cited by 41
RAGE Inhibitors in Neurodegenerative Diseases
Reddy, V. P., Aryal, P., & Soni, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041131 · Cited by 76
Yang, R., Chen, L., Wang, H., Xu, B., Tomimoto, H., & Chen, L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.035 · Cited by 73
Alpár, A., Ueberham, U., Brückner, M. K., Seeger, G., Arendt, T., & Gärtner, U. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.109 · Cited by 74
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs
Chung, M.-M., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Chen, Y.-L., Pei, D., Lin, C.-H., Shih, Y.-N., Yen, C.-H., Chen, S.-J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.017 · Cited by 66
Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66
Curcumin, Cardiometabolic Health and Dementia
Kim, Y., & Clifton, P. M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102093 · Cited by 76
Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models
Franklin, H., Clarke, B. E., & Patani, R. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101973 · Cited by 66
“While microglia express receptors implicated in Aβ clearance and phagocytosis (Simard et al., 2006), such as CD36, and RAGE (Yan et al., 1996; El Khoury et al., 1998) why Aβ continues to accumulate and AD pathology progresses despite recruitment of supposedly protective cells remains unclear.”
BackgroundAssessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
Chen, J., Mooldijk, S. S., Licher, S., Waqas, K., Ikram, M. K., Uitterlinden, A. G., Zillikens, M., & Ikram, M. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33012 · Cited by 72
“High-density lipoprotein cholesterol, mg/dL 49 (15) 53 (15) 58 (17)”
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Sphingolipids in apoptosis, survival and regeneration in the nervous system
de Chaves, E. I. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.018 · Cited by 71
“Interaction of Aβ with RAGE [213], α-7AChR [214], and p75 [215] has been linked to AD.”
BackgroundJuranek, J. K., Daffu, G. K., Wojtkiewicz, J., Lacomis, D., Kofler, J., & Schmidt, A. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00485 · Cited by 66
“It has been observed that in neurons, RAGE-AGE or RAGE-Amyloid β interaction results in increased oxidative stress and NF-κB cellular activation (Yan et al., 1996; Mattson and Camandola, 2001; Mattson, 2004), while in inflammatory cells, RAGE-S100 binding triggers immune cell migration and…”
BackgroundSelf-citationChange in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
Xue, J., Manigrasso, M., Scalabrin, M., Rai, V., Reverdatto, S., Burz, D. S., Fabris, D., Schmidt, A. M., & Shekhtman, A. (2016) · Structure · doi:10.1016/j.str.2016.06.021 · Cited by 65
“…2008; Xue et al., 2011), S100/calgranulins (Hofmann et al., 1999; Koch et al., 2010), High Mobility Group Box-1 (HMGB1) (Taguchi et al., 2000) proteins, amyloid-b peptides (Ab), b-sheet fibrils (Yan et al., 1996), lysophosphatidic acid (Rai et al., 2012b), and phosphatidylserine (He et al., 2011).”
Self-citationde Matos, A. M., de Macedo, M. P., & Rauter, A. P. (2018) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 66
Amyloid-Beta Peptide Is Toxic to Neurons In Vivo via Indirect Mechanisms
Walsh, D. T., Montero, R. M., Bresciani, L. G., Jen, A. Y. T., Leclercq, P. D., Saunders, D., EL-Amir, A. N., Gbadamoshi, L., Gentleman, S. M., & Jen, L.-S. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0485 · Cited by 66
β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide Production
Sutton, E. T., Hellermann, G., & Thomas, T. (1997) · Experimental Cell Research · doi:10.1006/excr.1996.3440 · Cited by 66
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
The importance of BDNF and RAGE in diabetes-induced dementia
Kim, O. Y., & Song, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105083 · Cited by 65
The p38MAPK-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission
Beamer, E. H., & Corrêa, S. A. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635636 · Cited by 69
“, 1999), amyloid-beta (Aβ) peptides (Yan et al., 1996; Takuma et al., 2009; Piras et al., 2016), associated with Alzheimer’s disease, and high-mobility group protein 1 (HMGB1) (Huebener et al.”
Chong, Y. H., Sung, J. H., Shin, S. A., Chung, J.-H., & Suh, Y.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009466200 · Cited by 65
Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide
Li, W., Tang, Y., Fan, Z., Meng, Y., Yang, G., Luo, J., & Ke, Z.-J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-27 · Cited by 65
Stogsdill, M. P., Stogsdill, J. A., Bodine, B. G., Fredrickson, A. C., Sefcik, T. L., Wood, T., Kasteler, S. D., & Reynolds, P. R. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0013oc · Cited by 65
Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G., & Nagele, R. G. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160284 · Cited by 65
Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease
Janota, C. S., Lemere, C. A., & Brito, M. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9319-7 · Cited by 77
“rebral blood vessels, microglia, and neurons [13, 103].”
Diabetic vascular dysfunction: Links to glucose‐induced reductive stress and VEGF
Tilton, R. G. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10092 · Cited by 69
“…cells from diabetic patients (Schmidt et al., 1999), as well as in macrophages from patients with renal failure and dialysis-related amyloidosis, in affected neurons in Alzheimer’s disease, and in vasculatures affected by autoimmune/inflammatory disorders (Miyata et al., 1996; Yan et al., 1996).”
Brazil, M. I., Chung, H., & Maxfield, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000937200 · Cited by 65
PrP and β‐Amyloid Fragments Activate Different Neurotoxic Mechanisms in Cultured Mouse Cells
Brown, D. R., Herms, J. W., Schmidt, B., & Kretzschmar, H. A. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01470.x · Cited by 65
Riuzzi, F., Sorci, G., & Donato, R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070049 · Cited by 70
Panaxydol and panaxynol protect cultured cortical neurons against Aβ25–35-induced toxicity
Nie, B., Jiang, X.-Y., Cai, J.-X., Fu, S., Yang, L., Lin, L., Hang, Q., Lu, P.-L., & Yang, L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.01.003 · Cited by 66
“The binding of fibrillar Ab to the receptor for advanced glycation endproducts (RAGE) initiates an oxidative inflammatory response (Yan et al., 1996).”
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier
Vendel, E., & de Lange, E. C. M. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8314-x · Cited by 73
“Microglia are important in the clearance and phagocy- tosis of AB (Yan et al. 1996, Rogers et al. 2002), but as AD progresses, microglia continue to produce pro-inflamma- tory cytokines and lose their ability to clear AB (Hickman et al. 2008).”
BackgroundRAGE acts as an oncogenic role and promotes the metastasis of human lung cancer
Chen, M., Chen, K., Chang, G., Lin, H., Wu, C., Kao, W.-H., Teng, C. J., Hsu, S., & Yang, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2432-1 · Cited by 70
Self-citationVascular disorder in Alzheimer’s disease: role in pathogenesis of dementia and therapeutic targets
Zloković, B. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00150-3 · Cited by 73
Styren, S. D., Kamboh, M. I., & Dekosky, S. T. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980713)396:4<511::aid-cne7>3.0.co;2-4 · Cited by 64
Kajkowski, E. M., Lo, C. F., Ning, X., Walker, S., Sofia, H. J., Wang, W., Edris, W., Chanda, P., Wagner, E., Vile, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011161200 · Cited by 63
Bohm, C., Chen, F., Sevalle, J., Qamar, S., Dodd, R., Li, Y., Schmitt-Ulms, G., Fraser, P. E., & St George-Hyslop, P. H. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.016 · Cited by 63
“RAGE is increased in brain blood vessels in AD cases (Yan et al., 1996).”
BackgroundPositive Feedback Loops in Alzheimer’s Disease: The Alzheimer’s Feedback Hypothesis
Doig, A. J. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180583 · Cited by 62
Ding, Y. J., Kantarcı, A., Badwey, J. A., Hastürk, H., Malabanan, A. O., & Dyke, T. E. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.647 · Cited by 71
Farber, S. A., Slack, B. E., & Blusztajn, J. K. (2000) · The FASEB Journal · doi:10.1096/fj.99-0853 · Cited by 64
Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
Berk, C., & Sabbagh, M. N. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0108-6 · Cited by 63
Chakrabarti, S., Sinha, M., Thakurta, I., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63
Shinpo, K., Kikuchi, S., Sasaki, H., Ogata, A., Moriwaka, F., & Tashiro, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02047-3 · Cited by 70
Amyloid and lipids in the pathology of Alzheimer disease
Roher, A. E., Kuo, Y.-M., Kokjohn, K. M., Emmerling, M. R., & Gracon, S. (1999) · Amyloid · doi:10.3109/13506129909007315 · Cited by 63
Self-citationIshii, K., Muelhauser, F., Liebl, U., Picard, M., Kühl, S., Penke, B., Bayer, T., Wiessler, M., Hennerici, M., Beyreuther, K., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-0786com · Cited by 62
Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo
Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.005 · Cited by 62
Hao, G., Dong, Y., Huo, R., Wen, K., Zhang, Y., & Liang, G. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1863-7 · Cited by 67
Bharadwaj, P., Solomon, T., Malajczuk, C. J., Mancera, R. L., Howard, M. J., Arrigan, D. W. M., Newsholme, P., & Martins, R. N. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.015 · Cited by 66
Sano, H., Nagai, R., Matsumoto, K., & Horiuchi, S. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00011-1 · Cited by 64
β-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain
Price, J., Sutton, T., Hellermann, A., & Thomas, T. (1997) · Neurological Research · doi:10.1080/01616412.1997.11740853 · Cited by 63
Foret, M. K., Orciani, C., Welikovitch, L. A., Huang, C., Cuello, A. C., & Carmo, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-06552-4 · Cited by 66
Milton, N. G. N. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00064-x · Cited by 69
Trougakos, I. P., Sesti, F., Tsakiri, E. N., & Gorgoulis, V. G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.024 · Cited by 65
Progress of RAGE Molecular Imaging in Alzheimer’s Disease
Kong, Y., Liu, C., Zhou, Y., Qi, J., Zhang, C., Sun, B., Wang, J., & Guan, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00227 · Cited by 61
“…Neuroscience | www.frontiersin.org 3 August 2020 | Volume 12 | Article 227 amyloid precursor protein (APP) β-site cleavage enzyme 1 (also known as BACE1), an important enzyme that cleaves amyloid precursors (Yan et al., 1996; Fang et al., 2010; Guglielmotto et al., 2012; Galasko et al., 2014).”
BackgroundMacrophage Pattern Recognition Receptors in Immunity, Homeostasis and Self Tolerance
Mukhopadhyay, S., Plüddemann, A., & Gordon, S. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-0901-5_1 · Cited by 61
Yatin, S. M., Aksenova, M. V., Aksenov, M. Y., Markesbery, W. R., Aulick, T., & Butterfield, D. A. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:3:183 · Cited by 72
“In vitro studies using synthetic peptide homologs of Aβ and its fragments showed that Aβ(25–35) retained the biological activity of Aβ(1–40) and Aβ(1–42) (Yankner et al., 1990; Abe and Kimura, 1996; Yan et al., 1996).”
Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview
Tran, M. H., Yamada, K., & Nabeshima, T. (2002) · Peptides · doi:10.1016/s0196-9781(02)00062-1 · Cited by 66
Yan, S. F., Barile, G. R., D’Agati, V. D., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0024-4 · Cited by 67
Self-citationReceptors for Advanced Glycosylation Endproducts in Human Brain: Role in Brain Homeostasis
Li, J., Dickson, D. W., Hof, P. R., & Vlassara, H. (1998) · Molecular Medicine · doi:10.1007/bf03401729 · Cited by 69
Are cerebrovascular factors involved in Alzheimer’s disease?
Kudo, T., Imaizumi, K., Tanimukai, H., Katayama, T., Sato, N., Nakamura, Y., Tanaka, T., Kashiwagi, Y., Jinno, Y., Tohyama, M., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00129-9 · Cited by 66
Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle
Weber, G. F. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00041-x · Cited by 66
The Neurobiology and Pharmacotherapy of Alzheimer's Disease
Félician, O., & Sandson, T. A. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.1.19 · Cited by 69
Regulation of Apoptosis by Presenilin 1
Wolozin, B. L., Alexander, P., & Palacino, J. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00041-4 · Cited by 63
Yamashita, S., Kiko, T., Fujiwara, H., Hashimoto, M., Nakagawa, K., Kinoshita, M., Furukawa, K., Arai, H., & Miyazawa, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150640 · Cited by 67
Dunning, C. J., McGauran, G., Willén, K., Gouras, G. K., O’Connell, D. J., & Linse, S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00262 · Cited by 60
C-peptide and diabetic neuropathy
Sima, A. A. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.9.1471 · Cited by 63
Zhao, C., Zhang, H., Li, H., Lv, C., Liu, X., Li, Z., Xin, W., Wang, Y., & Zhang, W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.002 · Cited by 59
“Ab is a pleiotropic ligand that can bind to receptors, such as receptors for advanced glycation end products (RAGE), at different membrane locations; RAGE is a cell surface multi-ligand receptor of the immunoglobulin superfamily (Yan et al., 1996).”
High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function
Akhter, F., Chen, D., Akhter, A., Sosunov, A. A., Chen, A., McKhann, G. M., Yan, S. F., & Yan, S. S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191236 · Cited by 67
Self-citationRegulation of RAGE for Attenuating Progression of Diabetic Vascular Complications
Win, M. T. T., Yamamoto, Y., Munesue, S., Saito, H., Han, D. G., Motoyoshi, S., Kamal, T., Ohara, T., Watanabe, T., & Yamamoto, H. (2011) · Experimental Diabetes Research · doi:10.1155/2012/894605 · Cited by 70
“Its endogenous and exogenous binding partners include AGE, high-mobility group box 1 (HMGB1), calcium-binding S100 protein group, β2-integrin Mac/CD11b, amyloid β-peptide, β-sheet fibrils, advanced oxidation protein products (AOPPs), complement C3a, lipopolysaccharides (LPS), and phosphatidylserine on the surface of a…”
BackgroundThe Chemerin Receptor CMKLR1 is a Functional Receptor for Amyloid-β Peptide
Peng, L., Yu, Y., Liu, J., Li, S., He, H., Cheng, N., & Ye, R. D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-141227 · Cited by 59
“Several receptors including the Toll-like receptors [7–10], scavenger receptors [11, 12], low-density lipoprotein receptorrelated protein [13], and the receptor for advanced glycation end products (RAGE) [14], have been identified as endogenous binding sites for A .”
BackgroundJhamandas, J. H., & MacTavish, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1051-04.2004 · Cited by 59
“These same pathways have also been shown to be activated by A in hippocampal neurons ( Wang et al., 2003 ) and implicated in degenerative processes in transgenic mice overexpressing the amyloid precursor protein (Otth et al., 2003).”
BackgroundEmerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Panza, F., Seripa, D., Solfrizzi, V., Imbimbo, B. P., Lozupone, M., Leo, A., Sardone, R., Gagliardi, G., Lofano, L., Creanza, B. C., et al. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1241232 · Cited by 59
Rong, L. L., Gooch, C., Szabolcs, M., Herold, K. C., Lalla, E., Hays, A. P., Yan, S. F., Yan, S. S. D., & Schmidt, A. M. (2005) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2005-00322 · Cited by 62
Self-citationHarashima, A., Yamamoto, Y., Cheng, C., Tsuneyama, K., Myint, K. M., Takeuchi, A., Yoshimura, K., Li, H., Watanabe, T., Takasawa, S., et al. (2006) · Biochemical Journal · doi:10.1042/bj20051573 · Cited by 59
Strazielle, N., Ghersi-Egea, J.-F., Ghiso, J., Dehouck, M.-P., Frangione, B., Patlak, C., Fenstermacher, J., & Gorevic, P. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.29 · Cited by 59
“Yan et al (52) have indicated that sAb-induced toxicity of endothelial cells from murine brain microvessels and PC12 cells is mediated by the receptor for advanced glycation end products (RAGE) and is the result of the generation of neurotoxic oxidants.”
BackgroundRegulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells
Klegeris, A., Walker, D. G., & McGeer, P. L. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00094-5 · Cited by 56
Muiswinkel, F. L. V., Raupp, S. F. A., Vos, N., Smits, H. A., Verhoef, J., Eikelenboom, P., & Nottet, H. S. L. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00019-3 · Cited by 59
Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700008 · Cited by 58
Self-citationHimori, N., Kunikata, H., Shiga, Y., Omodaka, K., Maruyama, K., Takahashi, H., & Nakazawa, T. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-015-3203-z · Cited by 58
Romero, R. J., Espinoza, J., Hassan, S. S., Gotsch, F., Kusanovic, J. P., Avila, C., Erez, O., Edwin, S. S., & Schmidt, A. M. (2008) · Journal of Perinatal Medicine · doi:10.1515/jpm.2008.076 · Cited by 60
Self-citationSink Hypothesis and Therapeutic Strategies for Attenuating Aβ Levels
Zhang, Y., & Lee, D. H. S. (2011) · The Neuroscientist · doi:10.1177/1073858410381532 · Cited by 57
Hudson, B. I., Moon, Y. P., Kalea, A. Z., Khatri, M., Marquez, C., Schmidt, A. M., Paik, M. C., Yoshita, M., Sacco, R. L., DeCarli, C. S., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.024 · Cited by 63
“RAGE is a cell surface receptor present on most neurovascular cell types including endothelium, neurons, glia, and circulating inflammatory cells [28,29].”
BackgroundSelf-citation
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.